Bank Of America Corp Intellia Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.33 Trillion
Q2 2025

A detailed history of Bank Of America Corp transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 429,148 shares of NTLA stock, worth $4.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

429,148

Previous 945,583 54.62%

Holding current value

$4.66 Million

Previous $6.72 Million 40.13%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.28 - $9.67 $3.24 Million - $4.99 Million	-516,435 Reduced 54.62%	429,148 $4.03 Million
Q1 2025 May 15, 2025	BUY	$7.11 - $12.8 $2.17 Million - $3.92 Million	305,887 Added 47.82%	945,583 $6.72 Million
Q4 2024 Feb 14, 2025	SELL	$11.41 - $21.09 $872,807 - $1.61 Million	-76,495 Reduced 10.68%	639,696 $7.46 Million
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $1.35 Million - $1.87 Million	68,457 Added 10.57%	716,191 $14.7 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $426,646 - $580,085	21,311 Added 3.4%	647,734 $14.5 Million
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $5.87 Million - $8.09 Million	246,638 Added 64.94%	626,423 $17.2 Million
Q4 2023 Feb 14, 2024	SELL	$23.16 - $32.34 $715,806 - $999,532	-30,907 Reduced 7.53%	379,785 $11.6 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $32.2 Million - $42.8 Million	-930,401 Reduced 69.38%	410,692 $16.7 Million
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $21.8 Million - $29.3 Million	653,308 Added 94.99%	1,341,093 $50 Million
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $12.8 Million - $24.3 Million	386,914 Added 128.6%	687,785 $24 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $3.92 Million - $5.22 Million	-72,764 Reduced 19.47%	300,871 $16.8 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $1.41 Million - $2.79 Million	36,552 Added 10.84%	373,635 $19.3 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $2.71 Million - $5.54 Million	46,588 Added 16.04%	337,083 $24.5 Million
Q4 2021 Feb 08, 2022	SELL	$100.76 - $138.36 $894,043 - $1.23 Million	-8,873 Reduced 2.96%	290,495 $34.3 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $2.26 Million - $3.02 Million	17,108 Added 6.06%	299,368 $40.2 Million
Q2 2021 Sep 13, 2021	BUY	$60.88 - $161.91 $17.2 Million - $45.7 Million	282,260 New	282,260 $45.7 Million

Others Institutions Holding NTLA

# of Institutions

333

Shares Held

96.5M

Call Options Held

1.76M

Put Options Held

1.05M

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $825M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Intellia Therapeutics, Inc. Transaction History